It's long been known that COVID-19 is more fatal for men than women, and new research links some of that excess risk to a gene known to cause a form of hair loss in males.
May 7, 2021
3
225
Patients with lasting symptoms of COVID-19 who completed a six-week, supervised rehabilitation program demonstrated significant improvements in exercise capacity, respiratory symptoms, fatigue and cognition, according to ...
May 7, 2021
0
23
Emerging evidence indicates that many currently defined aerosol generating procedures (AGPs) are unlikely to play any significant role in the generation of infectious aerosol that poses a risk to hospital staff. In a comment ...
May 7, 2021
1
7
According to the latest projections out by the CDC, the United States may see a sharp decline by July in COVID-19 cases—that is, if vaccinations continue and people wear masks where appropriate and adhere to social distancing.
May 7, 2021
0
14
Two doses of BNT162b2 are highly effective for preventing symptomatic and asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and other outcomes, according to a study published online May ...
May 7, 2021
0
6
Many American workers remain in jobs they'd rather leave—simply because they don't want to lose their health insurance, a new Gallup poll reveals.
May 7, 2021
0
6
The World Health Organization gave emergency use authorization Friday to a COVID-19 vaccine manufactured by China's Sinopharm, potentially paving the way for millions of the doses to reach needy countries through a U.N.-backed ...
May 7, 2021
0
4
As U.S. health officials prepare to authorize Pfizer's coronavirus vaccine for emergency use in younger children, a new poll shows that less than a third of parents would get their child vaccinated as soon as the shots are ...
May 7, 2021
0
6
With rich countries having bought up the majority of the world's COVID-19 vaccines, the rest of the world has relied on India—one of the world's largest vaccine producers and exporters—to increase access to doses.
May 7, 2021
0
2
Emergency use authorization for the Pfizer COVID-19 vaccine to be given to children ages 2 to 11 years could be sought from the U.S. Food and Drug Administration by September, the company said Tuesday.
May 7, 2021
0
9
